Aspire Biopharma Holdings, Inc. Entity Public Float
Financial Statements › Balance Sheet › Equity
dei:EntityPublicFloat · last filed 2026-04-08
- 2025-12-31: Entity Public Float $17.40M.
- 2024-06-28: Entity Public Float $87.00M.
- 2023-06-30: Entity Public Float $18.79M.
- 2022-06-30: Entity Public Float $286.93M.
| Period end | Entity Public Float |
|---|---|
| 2025-12-31 | $17.40M 10-K/A · filed 2026-04-08 |
| 2024-06-28 | $87.00M 10-K · filed 2025-04-07 |
| 2023-06-30 | $18.79M 10-K · filed 2024-03-11 |
| 2022-06-30 | $286.93M 10-K · filed 2023-03-21 |